Keyphrases
Tumor Growth
100%
Murine Model
100%
Pancreatic Cancer
100%
Diclofenac
100%
Inhibit Tumor
100%
VEGF Levels
100%
Arginase Activity
100%
White Blood Cells
18%
Peritoneal Macrophages
18%
Tumor Stroma
18%
Arginine Depletion
18%
Apoptosis
9%
Cyclooxygenase-1 (COX-1)
9%
Inflammation
9%
Tumor
9%
Tumor Cells
9%
Peritoneal Cavity
9%
Controversial Issues
9%
Protein Content
9%
Anti-inflammatory Effect
9%
Anti-inflammatory Drugs
9%
Arginase-1 (Arg-1)
9%
Pancreatic Tumor
9%
Cancer Model
9%
Further Treatment
9%
Treatment Development
9%
Tumor Inhibition
9%
Phospholipase A2 (PLA2)
9%
Vascular Sprouting
9%
Antitumoral
9%
Cyclooxygenase-2 Inhibitors
9%
Abdominal Cavity
9%
Malnourishment
9%
Tumor Weight
9%
Tumor Vascularization
9%
Antitumoral Effect
9%
Stroma Cells
9%
Vasculature Development
9%
Immunology and Microbiology
Macrophage
100%
Vasculotropin
100%
Leukocyte
100%
Vascularization
50%
Tumor Cell
50%
Mediator
50%
Peritoneal Cavity
50%
Antiinflammatory Activity
50%
Growth Inhibition
50%
Stroma
50%
Liquid
50%
Tumor Vascularization
50%
Protein Content
50%
Sprouting Angiogenesis
50%
Stroma Cell
50%
Abdominal Cavity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Vasculotropin
100%
Pancreas Cancer
100%
Diclofenac
100%
Arginase
100%
Neoplasm
45%
Arginine
18%
Inflammation
9%
Antiinflammatory Agent
9%
Antiinflammatory Activity
9%
Cancer Model
9%
Malnutrition
9%
COX-2 Inhibitor
9%
Cancer Inhibition
9%
Tumor Vascularization
9%
Phospholipase A2
9%
Prostaglandin Synthase
9%
Arginase 1
9%
Pancreas Tumor
9%
Veterinary Science and Veterinary Medicine
Vascular Endothelial Growth Factor
100%
Pancreatic Cancer
100%
Diclofenac
100%
Mouse
18%
Vascularity
18%
Leukocyte
18%
Macrophage
18%
Cyclooxygenase
9%
Peritoneal Cavity
9%
COX-2 Inhibitor
9%
Abdominal Cavity
9%
Pancreatic Tumor
9%